Hematologic malignancies: from clinical science to clinical practice - 2nd European Congress.
Ferreri, Andres J M
Hematologic malignancies: from clinical science to clinical practice - 2nd European Congress. [electronic resource] - IDrugs : the investigational drugs journal Apr 2006 - 242-6 p. digital
Publication Type: Congress
1369-7056
Antibodies, Monoclonal--therapeutic use
Antineoplastic Agents--chemistry
Boronic Acids--therapeutic use
Bortezomib
Hematologic Neoplasms--drug therapy
Humans
Ki-1 Antigen--immunology
Molecular Structure
Multiple Myeloma--drug therapy
Pyrazines--therapeutic use
Thalidomide--analogs & derivatives
Hematologic malignancies: from clinical science to clinical practice - 2nd European Congress. [electronic resource] - IDrugs : the investigational drugs journal Apr 2006 - 242-6 p. digital
Publication Type: Congress
1369-7056
Antibodies, Monoclonal--therapeutic use
Antineoplastic Agents--chemistry
Boronic Acids--therapeutic use
Bortezomib
Hematologic Neoplasms--drug therapy
Humans
Ki-1 Antigen--immunology
Molecular Structure
Multiple Myeloma--drug therapy
Pyrazines--therapeutic use
Thalidomide--analogs & derivatives